Kimberly J. Popovits
2018 - Genomic Health
In 2018, Kimberly J. Popovits earned a total compensation of $4.8M as President and Chief Executive Officer at Genomic Health, a 15% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $905,430 |
|---|---|
| Option Awards | $2,334,927 |
| Salary | $720,400 |
| Stock Awards | $794,715 |
| Total | $4,755,472 |
Popovits received $2.3M in option awards, accounting for 49% of the total pay in 2018.
Popovits also received $905.4K in non-equity incentive plan, $720.4K in salary and $794.7K in stock awards.
Rankings
In 2018, Kimberly J. Popovits' compensation ranked 2,159th out of 14,244 executives tracked by ExecPay. In other words, Popovits earned more than 84.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,159 out of 14,244 | 85th |
Division Services | 448 out of 2,377 | 81st |
Major group Health Services | 33 out of 218 | 85th |
Industry group Medical And Dental Laboratories | 7 out of 76 | 91st |
Industry Medical Laboratories | 7 out of 76 | 91st |
Source: SEC filing on April 25, 2019.
Popovits' colleagues
We found four more compensation records of executives who worked with Kimberly J. Popovits at Genomic Health in 2018.